KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.

David C. Qian,Madhusmita Behera,Conor E. Steuer,Suchita Pakkala,Jennifer W. Carlisle,Taofeek K. Owonikoko,Benjamin W. Fischer-Valuck,Aparna Hemant Kesarwala,Jeffrey Bradley,Walter J. Curran,Suresh S. Ramalingam,Kristin Higgins

KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.

2020

David C. Qian
Madhusmita Behera
Conor E. Steuer
Suchita Pakkala
Jennifer W. Carlisle
Taofeek K. Owonikoko
Benjamin W. Fischer-Valuck
Aparna Hemant Kesarwala
Jeffrey Bradley
Walter J. Curran
Suresh S. Ramalingam
Kristin Higgins

e21079Background: Recent progress in targeted therapy includes the demonstration of promising anti-tumor activity and safety of a KRAS inhibitor in patients with advanced malignancies harboring the...

Keywords:

Lung cancer
Internal medicine
KRAS
Oncology
non small cell
locally advanced
Pathology
Mutation
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations